Mackay Shields LLC Clovis Oncology, Inc. Transaction History

Mackay Shields LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$3.93 - $15.35 $240,036 - $937,547	-61,078 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $563,358 - $1.13 Million	43,978 Added 257.18%	61,078 $908,000
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $20.7 Million - $35.4 Million	-1,170,000 Reduced 98.56%	17,100 $424,000
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $20.5 Million - $35.2 Million	1,161,819 Added 4595.62%	1,187,100 $1.42 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $83,131 - $233,525	7,148 Added 39.42%	25,281 $454,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $70,488 - $118,751	2,400 Added 15.25%	18,133 $533,000
Q1 2018 May 03, 2018	BUY	$50.12 - $67.72 $788,537 - $1.07 Million	15,733 New	15,733 $831,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.